By altering the mRNA structure, researchers can create stable, non-immunogenic mRNA through in vitro transcription.

Brad Miller, Moderna's CIO, has driven technology innovation to help drive continued gains for the roughly $7 billion revenue ...

Moderna (MRNA) stock gains as company posts better than expected Q3 results driven by its updated COVID-19 vaccine. Read more ...

Moderna Chief Human Resources Officer Tracey Franklin has expanded her role to Chief People and Digital Technology Officer, overseeing the Company's talent and digital functions. Brad Miller, Chief ...

Good afternoon, ladies and gentlemen, and welcome, everyone, to the Maravai LifeSciences Third Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise ...

Drug maker Moderna, Inc. (MRNA) reported Thursday that its third-quarter net income was $13 million, compared to a net loss of $3.63 ...

and continuing to reduce our cost structure,” said Stephane Bancel, Chief Executive Officer of Moderna (MRNA). Published first on TheFly – the ultimate source for real-time, market-moving breaking ...

Moderna stock rises as Q3 revenue beats estimates at $1.83 billion, driven by strong U.S. COVID-19 vaccine sales. EPS of $0.03 exceeds expectations.

An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics ...

The progress made in understanding the protein folding problem — the mystery of how a protein’s underlying amino acid ...

In situations with more favorable market access contracts, Novavax is demonstrating the ability to compete with the mRNA ...